Vitalhub (TSE:VHI – Get Free Report) had its target price dropped by equities researchers at ATB Cormark Capital Markets from C$12.00 to C$10.25 in a research note issued on Monday, BayStreet reports. The brokerage presently has an “outperform” rating on the stock. ATB Cormark Capital Markets‘s price objective points to a potential upside of 57.21% from the stock’s current price.
Separately, Canaccord Genuity Group set a C$15.00 price objective on shares of Vitalhub and gave the company a “buy” rating in a research note on Friday, August 28th. Nine equities research analysts have rated the stock with a Buy rating. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of C$10.86.
Read Our Latest Analysis on VHI
Vitalhub Price Performance
TSE:VHI traded down C$0.48 during mid-day trading on Monday, reaching C$6.52. The stock had a trading volume of 481,442 shares, compared to its average volume of 297,780. The stock has a market cap of C$412.97 million, a P/E ratio of 54.33, a PEG ratio of 1.18 and a beta of 1.37. The business’s 50 day moving average is C$7.56 and its 200 day moving average is C$7.58. Vitalhub has a fifty-two week low of C$6.46 and a fifty-two week high of C$9.77.
Vitalhub (TSE:VHI – Get Free Report) last posted its earnings results on Thursday, November 12th. The company reported C$0.04 EPS for the quarter. Vitalhub had a net margin of 8.63% and a return on equity of 4.03%. The company had revenue of C$31.91 million during the quarter. Equities analysts expect that Vitalhub will post 0.23 EPS for the current year.
About Vitalhub
VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.
Further Reading
- Five stocks we like better than Vitalhub
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.
